Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for intravenous infusion pumps. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global intravenous infusion pumps market from 2025 to 2032. The intravenous infusion pumps market is positioned for significant growth, with a projected CAGR of 9.2% from 2025 to 2032, indicating a market value increase from USD 6.73 billion in 2025 to USD 12.37 billion by 2032.

Key Insights:

• Intravenous Infusion Pumps Market Size (2025E): USD 6.73 Bn
• Projected Market Value (2032F): USD 12.37 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 9.2%

Intravenous Infusion Pumps Market - Report Scope:

Intravenous infusion pumps are medical devices designed to deliver fluids, medications, and nutrients directly into a patient’s bloodstream in controlled amounts. These pumps are widely used in hospitals, ambulatory surgical centers, home healthcare settings, and specialty clinics to administer therapies such as chemotherapy, pain management, antibiotics, insulin, and parenteral nutrition. The market caters to diverse healthcare needs, offering a range of products such as volumetric infusion pumps, syringe pumps, ambulatory pumps, insulin pumps, and patient-controlled analgesia (PCA) pumps. Market growth is driven by increasing prevalence of chronic diseases, rising surgical procedures, growing demand for home-based healthcare, and advancements in smart and connected infusion technologies.

Market Growth Drivers:

The global intravenous infusion pumps market is propelled by several key factors, including the rising burden of chronic conditions such as diabetes, cancer, and cardiovascular diseases that require continuous medication administration. Increasing hospital admissions, expanding geriatric population, and growing need for accurate drug delivery systems support market expansion. Additionally, technological advancements such as wireless connectivity, smart pump systems, dose error reduction software (DERS), and integration with electronic health records (EHR) enhance patient safety and operational efficiency. The growing adoption of home infusion therapy and ambulatory care services further contributes to market growth.

Market Restraints:

Despite promising growth prospects, the intravenous infusion pumps market faces challenges related to high device costs and maintenance expenses, which may limit adoption in cost-sensitive healthcare settings. Risks associated with infusion errors, device malfunctions, and product recalls also pose concerns for healthcare providers and regulators. Stringent regulatory requirements for device approval and compliance, along with the need for skilled healthcare professionals to operate advanced infusion systems, can hinder market expansion. Additionally, cybersecurity risks associated with connected infusion devices present emerging challenges for manufacturers.

Market Opportunities:

The intravenous infusion pumps market presents significant growth opportunities driven by innovation, digital healthcare transformation, and expansion in emerging markets. The development of portable, wearable, and smart infusion pumps for home care and outpatient settings creates new avenues for market growth. Integration of artificial intelligence, remote monitoring, and cloud-based data management improves treatment accuracy and patient outcomes. Furthermore, increasing healthcare infrastructure investments in developing regions and rising demand for personalized medicine support market expansion. Strategic partnerships, product innovation, and investment in R&D are essential to capitalize on emerging opportunities and maintain competitive advantage.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the intravenous infusion pumps market globally?
• Which product types and applications are driving infusion pump adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the intravenous infusion pumps market?
• Who are the key players contributing to the intravenous infusion pumps market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global intravenous infusion pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global intravenous infusion pumps market, including Baxter International Inc., B. Braun Melsungen AG, and Fresenius Kabi AG, focus on innovation, product safety, and strategic collaborations to strengthen their market presence. These companies invest heavily in research and development to introduce advanced smart infusion systems with enhanced accuracy and connectivity features. Partnerships with hospitals, healthcare providers, and digital health companies facilitate technology integration and market expansion. Moreover, emphasis on regulatory compliance, patient safety, and cost-effective solutions supports sustained growth and competitiveness in the evolving infusion pumps landscape.

Key Companies Profiled:

• Baxter International
• B. Braun Melsungen AG
• Medtronic
• Micrel Medical Devices SA
• Boston Scientific Corporation
• BD
• Fresenius Kabi
• Smiths Medical
• F. Hoffmann-La Roche Ltd.
• Mindray

Intravenous Infusion Pumps Market Research Segmentation:

By Product Type

• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Insulin Infusion Pumps
• Patient-Controlled Analgesia Pumps

By Application

• Oncology
• Diabetes Management
• Pain Management
• Gastroenterology
• Pediatrics and Neonatology
• Others

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare
• Specialty Clinics

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Intravenous Infusion Pumps Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Pipeline Analysis
3.3. Product Type Adoption Analysis
3.4. Value Chain Analysis
3.5. Key Promotional Strategies by Manufacturers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Intravenous Infusion Pumps Market Outlook:
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Intravenous Infusion Pumps Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
4.3.3.1. Volumetric Infusion Pumps
4.3.3.2. Insulin Infusion Pumps
4.3.3.3. Syringe Infusion Pumps
4.3.3.4. Ambulatory Infusion Pumps
4.3.3.5. Patient-Controlled Analgesia (PCA) Infusion Pumps
4.3.3.6. Others
4.3.4. Market Attractiveness Analysis: Product Type
4.4. Global Intravenous Infusion Pumps Market Outlook: Application
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
4.4.3.1. Pediatrics/Neonatology
4.4.3.2. Chemotherapy
4.4.3.3. Chemotherapy Management
4.4.3.4. Pain Management
4.4.3.5. Hematology
4.4.3.6. Others
4.4.4. Market Attractiveness Analysis: Application
4.5. Global Intravenous Infusion Pumps Market Outlook: End-user
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
4.5.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
4.5.3.1. Hospitals & Clinics
4.5.3.2. Ambulatory Surgical Centers
4.5.3.3. Home Care Settings
4.5.3.4. Others
4.5.4. Market Attractiveness Analysis: End-user
5. Global Intravenous Infusion Pumps Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Intravenous Infusion Pumps Market Outlook:
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By End-user
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
6.4.1. Pediatrics/Neonatology
6.4.2. Chemotherapy
6.4.3. Chemotherapy Management
6.4.4. Pain Management
6.4.5. Hematology
6.4.6. Others
6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
6.5.1. Pediatrics/Neonatology
6.5.2. Chemotherapy
6.5.3. Chemotherapy Management
6.5.4. Pain Management
6.5.5. Hematology
6.5.6. Others
6.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
6.6.1. Hospitals & Clinics
6.6.2. Ambulatory Surgical Centers
6.6.3. Home Care Settings
6.6.4. Others
6.7. Market Attractiveness Analysis
7. Europe Intravenous Infusion Pumps Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product Type
7.2.3. By Application
7.2.4. By End-user
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
7.4.1. Volumetric Infusion Pumps
7.4.2. Insulin Infusion Pumps
7.4.3. Syringe Infusion Pumps
7.4.4. Ambulatory Infusion Pumps
7.4.5. Patient-Controlled Analgesia (PCA) Infusion Pumps
7.4.6. Others
7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
7.5.1. Pediatrics/Neonatology
7.5.2. Chemotherapy
7.5.3. Chemotherapy Management
7.5.4. Pain Management
7.5.5. Hematology
7.5.6. Others
7.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
7.6.1. Hospitals & Clinics
7.6.2. Ambulatory Surgical Centers
7.6.3. Home Care Settings
7.6.4. Others
7.7. Market Attractiveness Analysis
8. East Asia Intravenous Infusion Pumps Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Application
8.2.4. By End-user
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
8.4.1. Volumetric Infusion Pumps
8.4.2. Insulin Infusion Pumps
8.4.3. Syringe Infusion Pumps
8.4.4. Ambulatory Infusion Pumps
8.4.5. Patient-Controlled Analgesia (PCA) Infusion Pumps
8.4.6. Others
8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
8.5.1. Pediatrics/Neonatology
8.5.2. Chemotherapy
8.5.3. Chemotherapy Management
8.5.4. Pain Management
8.5.5. Hematology
8.5.6. Others
8.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
8.6.1. Hospitals & Clinics
8.6.2. Ambulatory Surgical Centers
8.6.3. Home Care Settings
8.6.4. Others
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Intravenous Infusion Pumps Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End-user
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
9.4.1. Volumetric Infusion Pumps
9.4.2. Insulin Infusion Pumps
9.4.3. Syringe Infusion Pumps
9.4.4. Ambulatory Infusion Pumps
9.4.5. Patient-Controlled Analgesia (PCA) Infusion Pumps
9.4.6. Others
9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
9.5.1. Pediatrics/Neonatology
9.5.2. Chemotherapy
9.5.3. Chemotherapy Management
9.5.4. Pain Management
9.5.5. Hematology
9.5.6. Others
9.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
9.6.1. Hospitals & Clinics
9.6.2. Ambulatory Surgical Centers
9.6.3. Home Care Settings
9.6.4. Others
9.7. Market Attractiveness Analysis
10. Latin America Intravenous Infusion Pumps Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End-user
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
10.4.1. Volumetric Infusion Pumps
10.4.2. Insulin Infusion Pumps
10.4.3. Syringe Infusion Pumps
10.4.4. Ambulatory Infusion Pumps
10.4.5. Patient-Controlled Analgesia (PCA) Infusion Pumps
10.4.6. Others
10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
10.5.1. Pediatrics/Neonatology
10.5.2. Chemotherapy
10.5.3. Chemotherapy Management
10.5.4. Pain Management
10.5.5. Hematology
10.5.6. Others
10.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
10.6.1. Hospitals & Clinics
10.6.2. Ambulatory Surgical Centers
10.6.3. Home Care Settings
10.6.4. Others
10.7. Market Attractiveness Analysis
11. Middle East & Africa Intravenous Infusion Pumps Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End-user
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
11.4.1. Volumetric Infusion Pumps
11.4.2. Insulin Infusion Pumps
11.4.3. Syringe Infusion Pumps
11.4.4. Ambulatory Infusion Pumps
11.4.5. Patient-Controlled Analgesia (PCA) Infusion Pumps
11.4.6. Others
11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
11.5.1. Pediatrics/Neonatology
11.5.2. Chemotherapy
11.5.3. Chemotherapy Management
11.5.4. Pain Management
11.5.5. Hematology
11.5.6. Others
11.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
11.6.1. Hospitals & Clinics
11.6.2. Ambulatory Surgical Centers
11.6.3. Home Care Settings
11.6.4. Others
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Mindray
12.3.1.1. Overview
12.3.1.2. Segments and Product Type
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Baxter International
12.3.3. B. Braun Melsungen AG
12.3.4. Medtronic
12.3.5. Micrel Medical Devices SA
12.3.6. Boston Scientific Corporation
12.3.7. BD
12.3.8. Fresenius Kabi
12.3.9. Smiths Medical
12.3.10. F. Hoffmann-La Roche Ltd.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations